(Reuters) - British bootmaker Dr Martens ( DOCMF ) said on Thursday it will reduce discounts in the Americas and EMEA regions in the current financial year and expects adjusted pre-tax profit to be in line with market expectations.

The Trump administration's steep tariffs on trade partners have significantly increased supply costs for companies like Dr Martens ( DOCMF ). Since most of its products are made in Vietnam, the company now faces a 46% reciprocal tariff, set to take effect in July.

However, the firm said it will keep average selling prices for its spring/summer and autumn/winter collections unchanged in the U.S. market as it continues to tighten costs and assess the impact of tariffs.

For the year ended March 2025, Dr Martens ( DOCMF ) logged an adjusted pre-tax profit of 34.1 million pounds ($46.2 million), above analysts' consensus of 30.6 million pounds, as per a company-compiled poll.